Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $319.0 million.

  • Mimedx's Liabilities and Shareholders Equity rose 3079.12% to $319.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 2242.51%. This contributed to the annual value of $263.9 million for FY2024, which is 1040.3% up from last year.
  • According to the latest figures from Q3 2025, Mimedx's Liabilities and Shareholders Equity is $319.0 million, which was up 3079.12% from $291.1 million recorded in Q2 2025.
  • Mimedx's 5-year Liabilities and Shareholders Equity high stood at $319.0 million for Q3 2025, and its period low was $168.2 million during Q1 2023.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $189.0 million (2023), whereas its average is $213.0 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 1537.61% in 2021, then soared by 3944.29% in 2023.
  • Mimedx's Liabilities and Shareholders Equity (Quarter) stood at $187.9 million in 2021, then decreased by 8.78% to $171.4 million in 2022, then soared by 39.44% to $239.0 million in 2023, then rose by 10.4% to $263.9 million in 2024, then increased by 20.87% to $319.0 million in 2025.
  • Its last three reported values are $319.0 million in Q3 2025, $291.1 million for Q2 2025, and $270.4 million during Q1 2025.